Skip to content

The Influence of Remimazolam on Postoperative Delirium in Patients with Hyperlipidemia:A Single-Center,Ambispective Cohort Study

The Influence of Remimazolam on Postoperative Delirium in Patients with Hyperlipidemia:A Single-Center,Ambispective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500097885
Enrollment
Unknown
Registered
2025-02-26
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative delirium

Interventions

Non-remimazolam group:None

Sponsors

The Affiliated Hospital of Southwest Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1: Hyperlipidemia; 2: Age >=18 years to undergo non-craniocerebral non-cardiac surgery under general anesthesia; 3: American Society of Anesthesiologists ASA grades I - III; 4: Postoperative hospital stay >=3 days.

Exclusion criteria

Exclusion criteria: 1: Patients with delirium or mental illness before surgery; 2: Allergic to or contraindicated with benzodiazepines; 3: There are serious cardiovascular diseases, liver and kidney insufficiency; 4: Patients with a history of substance abuse or who are taking psychotropic drugs.

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative delirium;

Secondary

MeasureTime frame
Severity of delirium;Incidence of adverse events in resuscitation room;Length of stay;Long-term cognitive function;Resuscitation room stay time;All-cause mortality six months after surgery;Relevant blood index;Demographic index;

Countries

China

Contacts

Public ContactXiaoxia Duan

The Affiliated Hospital of Southwest Medical University

duanxiaoxia@swmu.edu.cn+86 135 6863 5458

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026